Eunhye Oh

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Erratum: Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Erratum: Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Journal: Molecular therapy. Nucleic acids
Published: December 30, 2025

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC.

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC.

Journal: Oncology reports
Published: July 14, 2025

Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Rational design and applications of piperazine and cyclohexane ionizable lipids for PKU and SSADH deficiency.

Journal: Molecular therapy. Nucleic acids
Published: January 25, 2025

Stress Experience of COVID-19 Patients as Reported by Psychological Supporters in South Korea: A Qualitative Study.

Stress Experience of COVID-19 Patients as Reported by Psychological Supporters in South Korea: A Qualitative Study.

Journal: Frontiers in psychiatry
Published: December 14, 2021

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.

Journal: Cancer letters
Published: October 25, 2018

Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.

Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.

Journal: International journal of cancer
Published: December 01, 2017

Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.

Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.

Journal: Cancer letters
Published: July 11, 2017

Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells.

Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells.

Journal: Biochemical and biophysical research communications
Published: February 28, 2017

Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.

Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.

Journal: Cellular signalling
Published: January 09, 2017

Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.

Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.

Journal: Cancer letters
Published: September 06, 2016

Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.

Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.

Journal: Cancer letters
Published: March 24, 2016

Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.

Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.

Journal: Biochimica et biophysica acta
Published: December 01, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026